JOHN BEAN TECHNOLOGIES CORPORATION v. MORRIS & ASSOCIATES, INC
Contributed by Knobbe Martens. Originally published on Patexia; republished here as part of the LexDana archive.
Federal Circuit Summary
Before Prost, Reyna, and Wallach. Appeal from the United States District Court for the Eastern District of Arkansas.
Summary: Pre-reexamination conduct cannot be a basis for equitable estoppel if the asserted claims were substantively amended and narrowed during reexamination.
John Bean and Morris are competitors in the poultry chiller market. John Bean told Morris's customers that Morris's product infringed John Bean's patent. Morris sent a letter to John Bean challenging the validity of the patent. John Bean received the letter, but never responded. More than ten years later, John Bean filed an ex parte reexamination request and amended the claims. After the reexamination certificate issued, John Bean sued Morris. The District Court granted summary judgement in favor of Morris, finding that John Bean's suit was barred by equitable estoppel. The District Court relied primarily on Morris’ letter to John Bean as showing that John Bean believed Morris was selling an infringing product and waited years to sue.
The Federal Circuit reversed. At the time of Morris’s letter, John Bean could not have engaged in misleading conduct or silence with respect to the reexamined claims because those claims did not issue until years later. Thus, the district court erred in granting summary judgment based on equitable estoppel.
This case is: JOHN BEAN TECHNOLOGIES CORPORATION v. MORRIS & ASSOCIATES, INC
Written by: Adam Powell and Lindsay Laddaran
Edited by: Paul Stewart
More insights
Federal Circuit Affirms Invalidation of Patent for Lack of Enablement of Claims Directed to a Method of Treating a Patient with a Unit Dosage in Wyeth Llc v Astrazeneca Pharmaceuticals Lp
Written by : Eric Furman, Ph.D. and Ashley C. Morales Key Takeaway: Federal Circuit invalidates patent claims directed to a method for treating non-small cell lung cancer through administration of “a unit dosage” of an irreversible epidermal…
When About Becomes Indefinite Federal Circuit Provides Guidance for Life Science Patent Applications Regarding Limits of Approximation in Enviro Tech v Safe Foods
Written by : Jason J. Jardine and Kenneth O. Aruda, Ph.D. Key Takeaway: The term “about” remains useful in biotech and pharmaceutical claims, but only if the patent provides objective guidance about what the term means. Absent that guidance,…
When Any Patent Means No Patent Federal Circuit Reverses Non Specific Verdict
Written by : Brian C. Barnes and Sophia F. Zahn OLLNOVA TECHNOLOGIES LTD. v. ECOBEE TECHNOLOGIES ULC [OPINION] Before Chen , Cunningham, and Stark. Appeal from the United States District Court for the Eastern District of Texas. Summary : A verdict form…